Why procurement struggles with TAVI
Procurement teams often face a tight knot of problems: clinical outcomes tied to device choice, unpredictable costs, and delivery systems that don’t fit the cath lab workflow. You’ll see similar vendors but wide variance in training support and service uptime. When teams match device specs against clinical needs, questions about cross-compatibility and disposables crop up fast — especially for teams managing budgets and clinician expectations around interventional medical devices.
Pinpoint the real problems to solve
Stop treating specifications as the whole answer. Common root problems are: mislabeled performance claims, lack of hands-on clinician evaluation, unclear total cost of ownership, and supply chain risks. Each of those creates downstream delays, additional training costs, or device abandonment. Name the problem first, then pick a measurable goal — fewer complications, lower standby inventory, or faster case turnover — and build procurement criteria around that goal.
Concrete evaluation checklist
Use this checklist as a baseline: clinical evidence (RCTs, registry data), delivery catheter profile (diameter, flexibility), valve sizing range, hemodynamic performance benchmarks, ease of implantation, packaging and shelf life, sterile chain integrity, training availability, and vendor service SLAs. Assign numeric weights to criteria that matter locally (for example, femoral access rates or average case duration) so vendor comparisons are objective rather than conversational.
Pilot testing: how to run it without wasting cases
Run a short, structured pilot: three to five supervised cases per device with the same lead implanting physician, a checklist for intra-procedural issues, and explicit success metrics (procedure time, need for repositioning, paravalvular leak rate). Capture feedback immediately after each case. Avoid pilots that lack governance; vague pilots produce vague results.
Contract and logistics mistakes that cost money
Common procurement errors are easy to prevent. Don’t accept single-source supply without fallback stock or warranty clauses. Neglecting lot traceability or on-site technician response times creates risk. Watch for hidden consumable costs and don’t assume packaging sizes match your cath lab inventory cadence. Negotiate clear terms on training refreshers and device replacement for manufacturing defects.
Experience and trust: a real-world anchor
Procurement confidence grows from exposure to the market and to peers who’ve tested devices on volume cases — many catheter manufacturers present live demonstrations and data at major events like MEDICA in Düsseldorf, which helps teams compare hands-on performance and service models. That exposure, paired with verification of ISO 13485 and published clinical registries, builds credibility. If you evaluate suppliers, verify facility oversight, certificates, and clinical follow-up processes; one practical source to review supplier capabilities is the catheter manufacturer listings and specifications that show manufacturing transparency.
Alternatives and when to use them
If a full product switch isn’t viable, consider staged approaches: consignment stock to reduce upfront spend, shared-supplier models to preserve clinician choice, or a limited-scope adoption for specific patient anatomies. Each alternative reduces immediate risk but requires tighter monitoring of outcomes and inventory to prevent hidden costs.
Actionable first steps and final synthesis
Create a short procurement protocol: define measurable goals, deploy the checklist, run a time-boxed pilot, and lock supply terms that protect service and traceability. Keep clinicians engaged with simulated practice and immediate feedback loops. These steps turn the mess of choices into a repeatable process, and they’re the exact practices that help teams compare performance and reliability when evaluating suppliers like Shunmei without relying on marketing claims alone.